These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. 99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease. Koulibaly PM; Nobili F; Migneco O; Vitali P; Robert PH; Girtler N; Darcourt J; Rodriguez G Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1009-13. PubMed ID: 12750851 [TBL] [Abstract][Full Text] [Related]
28. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults. Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088 [TBL] [Abstract][Full Text] [Related]
29. Different uptake of 99mTc-ECD adn 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping. Hyun Y; Lee JS; Rha JH; Lee IK; Ha CK; Lee DS Eur J Nucl Med; 2001 Feb; 28(2):191-7. PubMed ID: 11303889 [TBL] [Abstract][Full Text] [Related]
30. Validation of the leukocyte labeling procedure with a new kit for the preparation of technetium-99m exametazime injection. Martinez T; Gallego Peinado M; Sanchez Catalicio J; Perez Angel F; Contreras Gutiérrez J Nucl Med Commun; 2016 Apr; 37(4):432-4. PubMed ID: 26657217 [TBL] [Abstract][Full Text] [Related]
31. Diagnosis of brain death with technetium 99m hexamethylpropylene amine oxime. Costa DC; Motteux IM; McCready AC Eur J Nucl Med; 1991; 18(7):503-6. PubMed ID: 1915475 [TBL] [Abstract][Full Text] [Related]
32. Influence of radiolytic-produced hydrogen peroxide on the stability of commercial kit (99m) technetium-exametazime preparation. Martinez T; Miñana E; Martín-Falquina TC; Fuente T J Labelled Comp Radiopharm; 2014 Jan; 57(1):49-52. PubMed ID: 24448745 [TBL] [Abstract][Full Text] [Related]
33. 99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease. Nobili F; Koulibaly PM; Rodriguez G; Benoit M; Girtler N; Robert PH; Brugnolo A; Darcourt J Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):357-63. PubMed ID: 17220817 [TBL] [Abstract][Full Text] [Related]
34. 99mTc-HMPAO as a tracer of cerebral blood flow in newborn infants. Børch K; Greisen G J Cereb Blood Flow Metab; 1997 Apr; 17(4):448-54. PubMed ID: 9143227 [TBL] [Abstract][Full Text] [Related]
35. 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow. Andersen AR Cerebrovasc Brain Metab Rev; 1989; 1(4):288-318. PubMed ID: 2701656 [TBL] [Abstract][Full Text] [Related]
36. Increased lung uptake of technetium-99m hexamethylpropylene amine oxime in systemic lupus erythematosus. Shih CM; Shiau YC; Wang JJ; Ho ST; Kao A Respiration; 2002; 69(2):143-7. PubMed ID: 11961428 [TBL] [Abstract][Full Text] [Related]
37. Oxido-reductive state: the major determinant for cellular retention of technetium-99m-HMPAO. Jacquier-Sarlin MR; Polla BS; Slosman DO J Nucl Med; 1996 Aug; 37(8):1413-6. PubMed ID: 8708786 [TBL] [Abstract][Full Text] [Related]
38. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection. Gratz S; Behr T; Herrmann A; Dresing K; Tarditi L; Franceschini R; Rhodes B; Stürmer KM; Becker W Eur J Nucl Med; 1998 Apr; 25(4):386-93. PubMed ID: 9553168 [TBL] [Abstract][Full Text] [Related]
39. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168 [TBL] [Abstract][Full Text] [Related]
40. SPECT image analysis using statistical parametric mapping: comparison of technetium-99m-HMPAO and technetium-99m-ECD. Patterson JC; Early TS; Martin A; Walker MZ; Russell JM; Villanueva-Meyer H J Nucl Med; 1997 Nov; 38(11):1721-5. PubMed ID: 9374340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]